Date: March 11, 2025
Renowned Cancer Researcher Honored in 2025
The American Association for Cancer Research (AACR) and the Pezcoller Foundation proudly announce that Douglas Hanahan, PhD, FAACR, has been awarded the 2025 Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research. Hanahan, a Ludwig Distinguished Scholar at the Ludwig Institute for Cancer Research in Lausanne, Switzerland, will be celebrated at the AACR Annual Meeting 2025, held April 25-30 in Chicago.
Groundbreaking Contributions to Cancer Science
Hanahan’s pioneering work has reshaped cancer research. He co-authored the “Hallmarks of Cancer” with Robert Weinberg, PhD, providing a vital framework for understanding cancer’s complexity. Using innovative mouse models, he defined multistep tumorigenesis and revealed how tumors interact with their microenvironment. His discoveries include the “angiogenic switch” with Judah Folkman, MD, and recent advances in cancer neuroscience, linking neuronal signaling to metastasis.
Praise from Cancer Research Leaders
“Dr. Hanahan’s innovative research has driven profound advancements in cancer biology,” said AACR CEO Margaret Foti, PhD, MD (hc). “His work inspires progress against cancer worldwide,” added Enzo Galligioni, MD, president of the Pezcoller Foundation.
A Legacy of Excellence in Oncology
With over 25 years of impact, Hanahan’s achievements include the AACR Lifetime Achievement Award and membership in the National Academy of Sciences. Details of his award lecture at AACR 2025 will be announced soon.
Contact and More Information
Media Contact: Kathleen Medora, kathleen.medora@aacr.org, 215-290-5408
More Info: https://www.aacr.org/about-the-aacr/newsroom/
Related Article: